Vanguard Group Inc. Reduces Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)
Vanguard Group Inc. cut its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 1.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,680,444 shares of the biotechnology company’s stock after selling 59,727 shares during the period. Vanguard Group Inc. […]
Vanguard Group Inc. cut its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 1.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,680,444 shares of the biotechnology company’s stock after selling 59,727 shares during the period. Vanguard Group Inc. […]